Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: First Asian Pacific working party on functional dyspepsia

被引:48
作者
Talley, NJ [1 ]
Lam, SK
Goh, KL
Fock, KM
机构
[1] Univ Sydney, Nepean Hosp, Dept Med, Penrith, NSW 2751, Australia
[2] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China
[3] Univ Malaya, Kuala Lumpur, Malaysia
[4] Univ Hosp, Kuala Lumpur, Malaysia
[5] Natl Univ Singapore, Fac Med, Singapore 117548, Singapore
[6] New Changi Hosp, Singapore, Singapore
关键词
antisecretory cisapride; domperidone; endoscopy; functional dyspepsia; H-2; blocker; H-pylori; management trials; non-ulcer dyspepsia; prokinetic; proton pump inhibitor;
D O I
10.1111/j.1440-1746.1998.tb00644.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Dyspepsia is most optimally defined as pain or discomfort centred in the upper abdomen. The symptom complex may be caused by peptic ulcer disease, gastro-oesophageal reflux, or gastric cancer but is most often due to functional (or non-ulcer) dyspepsia. While upper endoscopy is the method of choice to determine the underlying cause of dyspepsia, it is expensive. A more pragmatic approach is needed in the Asia-Pacific region where health services are limited. A detailed treatment algorithm is given for managing patients presenting with new-onset dyspepsia and documented functional dyspepsia after endoscopy, and evidence to support this approach is reviewed. Prompt endoscopy is recommended for patients with alarm fea-tures. In patients without alarm features, treatment for 2-4 weeks with an empirical anti-secretory or prokinetic agent, followed by investigation using non-invasive Helicobacter pylori testing and treatment for patients who do not respond or relapse, is recommended. Trials of management strategies are now needed to establish the efficacy and cost-effectiveness of the approaches recommended.
引用
收藏
页码:335 / 353
页数:19
相关论文
共 123 条
[111]  
Talley NJ., 1991, Gastroenterol. Int, V4, P145
[112]  
TALLEY NJ, 1998, IN PRESS GASTROENTER
[113]  
TATSUTA M, 1992, ALIMENT PHARM THERAP, V6, P221
[114]   LONG-TERM ORAL CISAPRIDE IMPROVES INTERDIGESTIVE ANTRODUODENAL MOTILITY IN DYSPEPTIC PATIENTS [J].
TESTONI, PA ;
BAGNOLO, F ;
FANTI, L ;
PASSARETTI, S ;
TITTOBELLO, A .
GUT, 1990, 31 (03) :286-290
[115]  
THOR P, 1996, NEUROGASTROENT MOTIL, V8, P194
[116]  
TOCHIHARA M, 1993, MED CONSULT NEW REME, V30, P65
[117]   DISTINCT PROFILES OF GASTRITIS IN DYSPEPSIA SUBGROUPS - THEIR DIFFERENT CLINICAL-RESPONSES TO GASTRITIS HEALING AFTER HELICOBACTER-PYLORI ERADICATION [J].
TRESPI, E ;
BROGLIA, F ;
VILLANI, L ;
LUINETTI, O ;
FIOCCA, R ;
SOLCIA, E .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (10) :884-888
[118]   EFFICACY OF CISAPRIDE IN FUNCTIONAL DYSPEPSIA RESISTANT TO DOMPERIDONE OR METOCLOPRAMIDE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
VANOUTRYVE, M ;
DENUTTE, N ;
VANEEGHEM, P ;
GOORIS, JP .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 :47-53
[119]   Sir Henry Wellcome medal and prize - A prospective study of Helicobacter pylori non-ulcer dyspepsia [J].
Velanovich, V .
MILITARY MEDICINE, 1996, 161 (04) :197-199
[120]   ENDOSCOPY IN THE EVALUATION OF DYSPEPSIA [J].
WHITE, LJ .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (02) :266-269